Clinical study of patients with major depressive disorder and healthy participants to examine the usefulness of the brain network marker program using fMRI for the diagnosis and stratification of major depressive disorder

Okada Go0 个研究点目标入组 390 人开始时间: 2022年10月12日最近更新: 2023年10月17日

试验速览

暂无简介。

•[Patients]
•(1)Men and women aged between 20 and 75 at the time of consent acquisition.
•(2)Patients with major depressive disorder using M.I.N.I. measured after obtaining the consent.
•(3)Patients who provide written and voluntary consent for participation in this study.
•[Healthy participants]
•(1)Men and women aged between 20 and 75 at the time of consent acquisition.
•(2)Those whose M.I.N.I. results measured after obtaining consent are not psychiatric disorders.
•(3)Participants who provide written and voluntary consent for participation in this study.

•[Patients]
•(1)Patients with mental status that makes it difficult to understand the purpose of the study.
•(2)Patients who meet any of the following criteria:
•-Patients with depression with psychotic features.
•-Patients who have been diagnosed with bipolar disorder or schizophrenia using DSM-5.
•-Patients who have been diagnosed with substance abuse within 6 months prior to obtaining consent.
•-Patients who have been treated for an anxiety disorder within 6 months prior to obtaining consent.
•-Patient who have a comorbid personality disorder at the time of consent acquisition.
•(3)Patients with significant suicidal tendencies.
•(4)Patients with contraindications to MRI.
•(5)Patients who are deemed inappropriate as research participants by the principal investigator or a subinvestigator.
•[Healthy participants]
•(1)Participants with current or history of psychiatric or neurological disorders.
•(2)Participants with contraindications to MRI.
•(3)Participants who are deemed inappropriate as research participants by the principal investigator or a subinvestigator.

发起方

Okada Go